Orthofix International reported $-2.22M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Accuray USD 2.54M 6.49M Dec/2024
AngioDynamics USD -6.35M 4.55M Sep/2025
Artivion USD 2.42M 4.07M Dec/2025
AtriCure USD 8.96M 8.85M Jun/2026
Dexcom USD 249.1M 49.6M Jun/2026
EDAP TMS EUR -9.08M 4.07M Mar/2026
Globus Medical USD 151.57M 27.27M Jun/2026
Inogen USD -5.96M 373K Sep/2024
Insulet USD 95M 3.9M Jun/2026
Integra LifeSciences USD 4.48M 9.1M Jun/2026
J&J USD 5.53B 299M Jun/2026
Medtronic USD 1.24B 100M Mar/2026
Mesa Laboratories USD -1.68M 5.1M Dec/2024
Orthofix International USD -2.22M 20.57M Dec/2025
Plus Therapeutics USD -6.95M 1.23M Mar/2026
Smith & Nephew USD 303M 10M Jun/2026
STAAR Surgical USD 8.06M 2.85M Jun/2026
Stryker USD 1.28B 531M Jun/2026
Tandem Diabetes Care USD -21.17M 775K Jun/2026
Teleflex USD 99.69M 107.85M Jun/2026
Veracyte USD 25.49M 3.22M Jun/2026
Zimmer Biomet Holdings USD 198.3M 39.8M Jun/2026